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ALTERNATIVE MODELS OF INSTANT DRUG TESTING: 
 EVIDENCE FROM AN EXPERIMENTAL TRIAL 
 
ABSTRACT 
OBJECTIVE: This study describes and provides relapse and recidivism outcome findings related 
to an experimental trial evaluating the viability of frequent, random drug testing with 
consequences for use. 
METHODS: The sample consisted of 529 offenders released on parole. An experimental design 
with random assignment to one of three groups was employed. The Experimental Group received 
frequent, random drug testing with instant results, immediate sanctions, and referral for 
substance abuse treatment. Control Group I received frequent, random drug testing and treatment 
referral, but did not receive immediate test results or immediate sanctions. Control Group II 
followed standard parole practice. Members of this group were not tested on a random basis and 
did not receive immediate sanctions. Repeated measures ANOVA and survival analysis 
techniques were used to explore group differences.  
RESULTS: Frequent monitoring of drug use with randomized testing protocols, immediate 
feedback, and certain consequences is effective in lowering rates of relapse and recidivism. The 
effectiveness is particularly salient in the short-term during the period of exposure to testing 
conditions.  
CONCLUSIONS: The findings lend support to the use of randomized testing with swift and 
certain sanctions with parolees. Additional quality evidence is necessary to generalize and refine 
findings from this study and others that focus on sanction certainty. Future replications must 
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consider the immediacy of test result and sanction execution as well as the length of exposure to 
randomized testing periods.     
 
KEYWORDS: Community Supervision, Conditions Evaluation, Corrections, Parolees, Prisoner 
Reentry, Substance Use  
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ALTERNATIVE MODELS OF INSTANT DRUG TESTING: EVIDENCE FROM AN 
EXPERIMENTAL TRIAL 
The tremendous growth in incarcerated populations has necessitated community 
correctional alternatives. Parole populations have increased three-fold since 1980 and remained 
relatively stable since 2006 (Sourcebook of Criminal Justice Statistics, 2011). Approximately 
728,000 individuals were released in 2009 and supervised under conditional terms (Glaze, 
Bonczar, & Zhang, 2010). The largest sub-population of parolees is those with drug-involved 
convictions (Glaze et al., 2010). Histories of drug use are prominent among those convicted on 
drug-involved offenses (King & Mauer, 2002) as well as among generalized offender 
populations (Lattimore & Visher, 2010; Mallik-Kane & Visher, 2008; Mumola & Karberg, 
2006). Many are in need of substance abuse treatment, but few receive services and continue to 
battle with unresolved issues while in the community (Mallik-Kane & Visher, 2008; National 
Research Council, 2008). With needs left unmet, parolees with drug use and abuse histories 
serve as one of the most difficult populations to manage (Mallik-Kane & Visher, 2008; National 
Research Council, 2008). Indeed, nearly half of this population will fail to successfully complete 
terms of supervision and many will find themselves back in prison as a result of parole 
revocation (Glaze, et al., 2010; Solomon, Osborne, Winterfield, Elderbroom, Burke, Stroker, 
Rhine, & Burrell, 2008) and recidivism (Beck & Shipley, 1989; Langan & Levin, 2002). 
Interest has grown in implementing programs and conditions that utilize drug testing 
protocols, especially those involving instant results, to inform caseload management decision-
making. Practitioners, policy makers, and academics have looked to the evidence of the Hawaii 
Opportunity Probation and Enforcement (HOPE) quasi-experimental trial and randomized 
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replication in anticipation of gaining similar successes (see Hawken & Kleiman, 2009). 
However, there are a number of lingering questions that remain about the HOPE model. It is not 
clear if behavioral management interventions akin to HOPE would translate across correctional 
populations to affect parolees. More importantly, it remains to be seen whether the essential 
elements of HOPE – the combination of randomized drug testing and sanctions – are necessary 
to reproduce outcomes. This concern was raised by Hawken and Kleiman (2009) and has yet to 
be explored. By design, the study reported here uses a longitudinal experimental examination of 
intensive conditions for parolees that manipulate drug test and sanction procedures to answer 
these questions. Participants in this research were randomly assigned to conditions with salient 
variations in drug testing (i.e., randomized or non-randomized testing) and sanctioning (i.e., 
immediate or delayed graduated sanctions for positive tests) schedules. These conditions also 
required participation in substance abuse treatment on a need basis. It was anticipated that 
assignment to these conditions would reduce the likelihood of relapse and recidivism and allow 
for observation of differential effects. 
Drug testing is commonly used to identify use, supervise, and manage risk among 
parolees with substance abuse histories. The ability to detect use has become increasingly more 
sophisticated, efficient, and effective (Carver, 2004). It has been suggested that testing has 
inherent value in holding parolees accountable for their behavior and deterring future drug use 
(Carver, 2004; Haapanen & Britton, 2002), enhancing the effect of substance abuse treatment 
participation (Anglin & Hser, 1990; National Research Council, 2008), and reducing the 
likelihood of relapse and recidivism (Taxman, 2008). 
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Drug testing protocols can serve an instrumental purpose to guide caseload decision-
making when protocols are randomized, results are instant, and sanctions are delivered.  The 
theoretical basis of such policies and tactics resides in learning theory.  It is postulated that 
associating negative outcomes with the undesired behavior should lead to the reduction in that 
behavior (Honig & Staddon, 1977; Skinner, 1938).  Within this theoretical model, the immediacy 
and certainty of the negative consequence are all critical to drug use desistance. Until now, there 
has been little research which has directly examined the efficacy of such proposals within the 
context of drug testing and treatment for offenders.  
One prominent example has been HOPE, which targeted probationers with substance 
abuse histories (Hawken & Kleiman, 2009). Contract, incentive, and sanction strategies were 
used to reinforce compliant behavior, punish non-compliant behavior, and hold participants 
accountable. Consequences for non-compliance were known and highly likely. Participants were 
subject to frequent, random drug testing. Violations resulted in swift and certain sanctions that 
consisted of short jail stays. Graduated sanctions were incorporated and included referral to 
treatment services for continued non-compliance. Sanctions were uniformly applied, known, and 
consistent with the initial behavioral contract for participation. 
Overall, the results of the HOPE evaluations were promising. Reductions in no-shows for 
community supervision appointments, positive drug tests, and recidivism were observed for the 
original quasi-experimental trial with six month follow-up as well as the replicated experimental 
trial with one year follow-up (Hawken & Kleinman, 2009). A number of secondary benefits were 
observed that have important implications for community correctional administrators. Hawken 
and Kleinman (2009; Hawken, 2010) suggested that HOPE assisted with resource allocation 
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determinations and can replace traditional processes of treatment assessment and referral. Drug 
testing results were instrumental in the identification of participants in need of intense services as 
well as those who may abstain from use. The perceived threat and reality of sanctions may deter 
some participants from use, but not those with entrenched use behaviors. Within-group self-
selection is common to many intervention strategies and was built into the HOPE model. 
Increased attention and resources were diverted to those who were observed to be struggling with 
continued drug use. 
In light of these benefits, approximately three million dollars of federal funding was 
made available from the Second Chance Act of 2007 to support additional replications (Office of 
Justice Programs, 2011). Preliminary evidence is still being generated. O’Connell, Visher, 
Martin, Parker, and Brent (2011) are currently evaluating a randomized trial in Delaware that 
incorporates parallel schedules of behavioral reinforcement though consequence certainty and 
swiftness. The six month conditions are administered through a probation office by probation 
administrators.  Preliminary trends from the experimental design for probationers from Alaska 
using similar critical elements to HOPE suggest reductions in positive drug tests, but these trends 
must be interpreted with caution (Carns & Martin, 2011). Difficulties in the research design such 
as small sample size (n=63), participant contamination, and the inability to generate comparison 
data for the control group limit the interpretation of results (Carns & Martin, 2011). 
The findings of HOPE and the design of the Delaware and Alaska trials are congruent 
with current best practice recommendations (Andrews & Bonta, 2006; Andrews, Zinger, Hoge, 
Bonta, Gendreau, & Cullen, 1990; Aos, Miller, & Drake, 2006; Landenberger & Lipsey, 2005; 
MacKenzie, 2000, 2006; Pearson, Lipton, Cleland, & Yee, 2002; Sherman, Gottfredson, 
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MacKenzie, Eck, Reuter, & Bushway, 1997), especially among those with substance abuse or 
dependency histories (Fletcher & Chandler, 2006; Prendergast, Podus, Finney, Greenwell, & 
Roll, 2006). Researchers have argued that such techniques should be paired with schedules of 
reinforcement that include certain and swift consequences (Boyum, Caulkins, & Kleiman, 2010; 
Harrell & Roman, 2001; Taxman, Soule, & Gelb, 1999). Indeed, the variable coupling of these 
components have benefitted participants of residential therapeutic communities (Inciardi, Martin, 
& Butzin, 2004; Knight, Simpson, & Hiller, 1999; Martin, Butzin, Saum, & Inciardi, 1999; 
Wexler, Melnich, Lowe, & Peters, 1999), drug courts (Belenko, 2001; Harrell, Mitchell, Hirst, 
Marlowe, & Merrill, 2002; Harrell & Roman, 2001; Gottfredson, Najaka, & Kearley, 2003), and 
community-based substance abuse treatment (Center for Substance Abuse Research, 1994; 
Friedmann, Rhodes, & Taxman, 2009) with observed improvement in relapse, revocation, or 
recidivism outcomes. Community-based supervision strategies similarly benefitted from the 
integration of behavioral management and reinforcement approaches (Friedmann et al., 2009; 
Taxman, 2008; Wodahl, Garland, Culhane, & McCarty, 2011).  
There is reason to question the generalizability of HOPE model effects. First, is the 
participant population. The model was developed for probationers and replications are largely 
focused on this target population. It is not clear if this model could be extended to parolees. 
Fundamentally, parolees are presumed to be higher-risk offenders than probationers (Gill, 2010). 
Hawken and Kleiman (2011) are testing the notion that HOPE can be extended to parolees with 
an experimental trial of 70 participants (35 per condition) in Washington. Preliminary trends 
from the trial indicate reductions in the rate of positive drug tests, utilization of incarceration 
beds, and conviction on new felony offenses six months post-condition assignment. Given the 
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small sample size and relatively short span of follow-up, these trends do cautiously suggest that 
HOPE model elements can be extended to parolees. 
Second, critical elements of the HOPE model need further examination.  Immediate 
sanctions were assigned for drug test violations and are the product of a hearing that generally 
takes place within 72 hours after the violation in the original model (Hawken & Kleinman, 
2009). Hearings for violations generally occurred within the same time frame in Alaska (Carns & 
Martin, 2011) and Washington (Hawken & Kleiman, 2011). As such, the sanctioning process is 
somewhat delayed. In Delaware, sanctions are to be imposed within hours of a violation 
(O’Connell et al., 2010). Variation in the timing of the sanction and its effect on outcomes is not 
clear. Swiftness of sanction is central to the theoretical tenants of behavioral conditioning and 
deterrence, but is difficult to manipulate and examine (O’Connell et al., 2011). Finally, there are 
concerns with drug testing schedules that serve as the indicator of behavior. Randomized testing 
is critical (Harrell & Kleiman, 2000). HOPE participants were randomly tested at least once a 
week for the first two months of participation (Hawken & Kleiman, 2009). The Delaware 
replication randomly tests once a week for the first three months and graduated sanctions for 
non-compliance include scheduled tests twice a week for a month (O’Connell et al., 2010). 
Alaska probationers averaged three random tests per month across a three month period (Carns 
& Martin, 2011), while Washington parolees averaged three random tests across a six month 
period (Hawken & Kleiman, 2011).  Variability in randomized testing schedules may also 
contribute to observed effects.  
The extant research shows promise for the use of randomized testing as an intervention 
for drug using or abusing offenders.  However, at least three significant questions remain.  First, 
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can results demonstrated with probationers be extended to parolees?  Second, what is the effect 
of differential timing (i.e., immediacy) of consequences?  Third, what is the effect of differential 
certainty of consequences?  From a social learning theory perspective, both the immediacy and 
certainty of consequences should have major impact on future behavior.  
Hence, the study reported here was designed to examine prior observed effects in the 
context of a parolee population and to begin to examine the role of immediacy and certainty of 
consequences in impacting relapse and recidivism.   Two central questions were examined. The 
first question examined “what was the relative efficacy of alternative drug testing models in 
terms of levels of relapse?” Relatedly, the second question was “what were the relative efficacy 
of the alternative drug testing models in terms of levels of recidivism?”     
METHODS 
Context 
 This study was conducted in a large urban county within a Midwestern industrialized 
state. The organizational context for the study conditions were increased prosecution and prison 
sentences for drug offenses along with high rates of self-reported substance abuse by individuals 
sentenced to prison on a new commitment and among probation or parole violators returning to 
prison in the study state. In recognition of the growing problems associated with the management 
of individuals with substance abuse issues, the Department of Corrections of the study state 
sought effective programs and procedures and were interested in collaborating in the study. The 
county received concentrated populations of individuals being released to the community from 
prison as well as individuals being sentenced to prison on new commitments for technical 
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violations. The proportion of releases and returnees with substance abuse issues was higher than 
other locations in the state. The conditions were conceived by the Department of Corrections and 
included institutional, field office, and programmatic unit staff. Moreover, stakeholders from 
multiple organizations were actively involved and committed to the program. These included 
representatives of the funding agency, local Sheriff’s Office, local substance abuse treatment 
service agencies, and the research team. 
Participants 
  An experimental design with random assignment to one of three groups was employed.  
Randomization was stratified for order of referral. Individual case files were screened for 
histories of drug problems by a regional community supervision field office during the pre-
parole process. All male subjects were considered eligible for the conditions if they had a history 
of drug problems, and had special community supervision terms that prohibited substance abuse, 
and were to be placed within one of several postal zones, and did not have chronic or urgent 
medical needs. Parolees under interstate compacts were excluded from participation. With the 
use of a randomization protocol eligible subjects were assigned to one of two community 
correctional field offices. All those randomly assigned to Field Office A were placed in the 
Experimental Group. All eligible subjects randomly assigned to Field Office B were placed in 
Control Group I or Control Group II. Each participant was assigned to a community supervision 
agent who explained the procedures to the individual and his family. Instructions on procedures 
and requirements for drug testing and the consequences for drug test violations were provided. 
All participants signed a written notice acknowledging they understood the requirements and 
conditions of the program.   
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 The sample consisted of 529 offenders. There were no violations of random assignment 
procedures. The randomization schedule targeted a 2:1:1 participant ratio for the Experimental 
Group, Control Group I, and Control Group II.  The actual Experimental Group consisted of 281 
participants, Control Group I consisted of 136 participants, and Control Group II of 112 
participants. Table 1 presents the demographic characteristics of the participants. Participants 
were slightly over 33 years of age. The vast majority was single and had never been married. 
They had served an average of two years in prison. Thirty-eight (38%) had a primary charge for 
a property offense, 32% with a drug offense, and 23% with a person offense. The remainder of 
participants were charged with nonviolent public safety offenses. Over half of the sample had 
previously served time in jail. Fifty-six percent had previously served time in prison. Nearly 
three-quarters of the group had served time in either prison or jail. Risk assessments were 
derived from variant of salient factor scores (Hoffman & Beck, 1974). Assault (Risk Assessment 
A) and property (Risk Assessment P) crime risks did not differ between the conditions. Over four 
in five had special conditions of their parole related to alcohol use. Substantial proportions 
reported problems with alcohol and illegal drugs. They tended to use alcohol in their middle 
teens and reported using alcohol at least once in the past three days. The majority had used 
cocaine and approximately one in four had used heroin. Marijuana use was reported by two 
thirds of the participants. Relatively small numbers reported using methadone, barbiturates, 
hallucinogens, and inhalants. In short, the participants represented the targeted sub-population of 
offenders. The group consisted of parolees with extensive prior records and histories of drug 
abuse. There were no statistically reliable differences observed between the three groups. [Insert 
Table 1 about here] 
Procedures 
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Measures 
 Three sources of archival data were used. The first, parole agent files, consisted of intake 
information conditions and the actual number of drug tests, days of incarceration, and referral for 
treatment. These data were collected by conditions staff and shared amongst stakeholders on a 
daily basis. Second, archival data was collected electronically from the state correctional 
management information system. Background information on all participants and follow-up 
community supervision performance data was gleaned from the system. Third, arrest outcomes 
were collected from the Law Enforcement Information Network (LEIN) on arrest outcomes 
during the 12 month follow-up.   
Independent Variables 
 All participants were involved in one of the following three conditions for the first six 
months following prison release. During the subsequent 12 month follow-up interval, all 
participants, regardless of condition, were subjected to the standard conditions of parole (i.e., the 
conditions that Control Group II was exposed to during the first six months). 
Experimental Group. Members of the Experimental Group received frequent, random 
drug testing with instant results, immediate sanctions, and referral for substance abuse treatment. 
Each weekday, the Experimental Group was required to call a toll free number to find out if they 
had been randomly selected for testing that day. If so, they were to report to the county jail to 
submit a urine sample between 12:00 p.m. and 7:00 p.m. The drug testing protocol assured that 
each individual in the Experimental Group was to be tested an average of twice per week. 
Individuals did not know which days they would be required to report until they called. A hand-
14 
 
held urine test device was used to obtain instant test results. The device allowed for monitoring 
the use of four drugs: alcohol, cocaine, opiates/heroin, and THC. All of the urine samples were 
forwarded onward to the laboratory for gas chromatography analysis. Lab tests covered eight 
substances: alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, codeine, 
hydromorphine, and methadone. Laboratory confirmations were available to conditions staff 
within several days. Instant test results were the primary indicator of drug use, regardless of the 
subsequent results from lab tests. The rate of false positives was near zero when instant results 
were compared to lab follow-up.  Less than 1% of false negatives were observed.  
Individuals who tested positive were immediately incarcerated for three days.  This was 
true each time they tested positive. Individuals who failed to report for testing were also 
incarcerated for three days each time they did not report. Three consecutive missed tests led to 
the pursuit of an abscond warrant. Those who were incarcerated for either a positive drug test or 
failure to report sanction were assessed for substance abuse treatment by drug counselors from a 
local non-profit treatment vendor while incarcerated and offered drug treatment. Through 
internal evaluation and assessment, counselors had discretion to recommend outpatient 
counseling (i.e., individual therapy, group counseling, drug and alcohol education classes and 
Alcoholics Anonymous or Narcotics Anonymous self-help meetings), intensive outpatient 
counseling or day treatment (i.e., less than 9 hours of direct weekly treatment for the first four 
weeks of enrollment that consisted of individual therapy, didactic education classes, group 
counseling, and self-help meetings), residential treatment (i.e., twenty four hour, seven day a 
week live-in programming with at least 30 hours of weekly treatment consisting of individual 
therapy, group counseling, self-help meetings, GED instruction, vocational and recreational 
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therapy), or self-help meetings (i.e., Alcohol, Narcotics, and Cocaine Anonymous). This referral 
was an offer of treatment and was not a condition of community supervision. 
Control Group I. Control Group I was designed to allow for the examination of the 
degree to which any effects observed were attributable to the immediacy of the test results and 
sanction. As in the Experimental Group, Control Group I participants were required to call the 
toll free number each working day to find out if they had been randomly selected for substance 
abuse testing. If so, they also reported to the county jail to submit a urine sample between 12:00 
p.m. and 7:00 p.m. Each individual in Control Group I was to be tested an average of two times 
per week following the same testing protocol as the Experimental Group. However, urine 
samples were only sent to the laboratory for screening. No instant tests were done on Control 
Group I. Once the urine screen was submitted, they were allowed to leave the county jail and 
await contact from community supervision agents who reviewed laboratory results. The results 
were available to agents within two to three days after submission. Standard sanctioning 
procedures were in effect for positive test results and failure to appear. The first testing violation 
resulted in referral for outpatient treatment, the second resulted in referral for inpatient drug 
treatment, and the third resulted in case review for possible revocation of community 
supervision. Hence, the Control Group I received frequent random testing and treatment referral, 
but did not receive immediate test results or immediate sanctions. 
Control Group II.  Control Group II mirrored standard parole. This group was tested for 
illegal drugs only when they reported to their community supervision agent. Report dates were 
scheduled once a month. They were not tested on a random basis nor immediately incarcerated 
for positive drug tests. They were also referred to treatment when appropriate. Hence, Control 
16 
 
Group II received standard testing frequency, feedback, sanctions, and treatment referral. [Insert 
Table 2 about here] 
Implementation Checks 
 A variety of variables were used to assess the implementation of the experimental 
conditions. All but one of the implementation check variables were collected for one year 
following prison release. The first six months reflected parolee behavior during the time they 
were exposed to the different conditions. The next six months served as a follow-up of release 
from the conditions and a return to standard parole.  
 Frequency of Tests. Frequency of tests was defined as the number of drug tests 
administered. Since the experimental conditions were to be exposed to differential testing, this 
measure was used to observe variation in testing.    
 Frequency of Tests by Week. Frequency of tests by week was an alternative measure of 
differential testing and was defined as the number of drug tests administered by week. The ratio 
measure was used to scale the frequency of tests variable by a denominator of weeks exposed to 
the conditions. Weeks were calculated at seven day intervals.  
 Jail Percent Received. Jail percent received was defined as the proportion of participants 
who were placed in jail. It is a dichotomous measure of whether a jail sanction had been 
received. The experimental conditions were to be exposed to differential sanctions. For the 
Experimental Group, this measure represented the proportion of participants who received a 
sanction for a positive drug test. The Experimental Group may also have received a jail sanction 
for failure to report for testing, but these instances were excluded from the measure. For Control 
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Group I and II, this measure represented the proportion of participants who were placed in jail at 
the discretion of their parole officer or from contact with law enforcement agencies.   
 Overall Jail Days. Overall jail days was defined as the number of jail days received. The 
measure represented the length of time spent in jail by experimental condition. As an average 
across conditions, this measure includes participants within conditions who were and were not 
placed in jail.   
 Jail Days If Jailed. Jail days if jailed was used as an alternative measure of length of time 
spent in jail and was defined as the number of jail days received by participants within 
conditions. The measure represented the length of time spent in jail only for the sub-group of 
participants who received a jail sanction. 
 Percent Admitted to Treatment. Percent admitted to treatment is defined as the proportion 
of participants who were admitted to substance abuse treatment. This was the only 
implementation check variable that was only collected for the first six months following prison 
release.  The experimental conditions were exposed to differential treatment. The use of a 
treatment admission measure is preferred since assessment or referral protocols were built into 
the Experimental and Control Group I conditions and referral processes are common to Control 
Group II.            
Dependent Variables 
  All dependent variables were collected for 18 months following prison release.  The first 
six months reflected parolee behavior during the time they were exposed to the different 
conditions and the next 12 months a one year follow-up from conditions release. 
18 
 
Relapse. Relapse was defined as a positive drug test. Two metrics were used.  First, a 
ratio measure of proportionality was used to scale positive tests since the protocol for the 
conditions called for differential rates of drug testing and would artifactually produce higher 
frequencies of positive drug tests in Experimental and Control Group I. Second, a dichotomous 
measure was used to present the percentage of participants who tested positive for at least one 
drug test. 
Re-arrest. Re-arrest was defined as any arrest for a new felony offense. This dichotomous 
measure reflected in which an individual was arrested, but may not have been convicted for an 
offense. 
RESULTS 
 The purpose of this study was to determine the relative effects of various components of 
drug testing and sanctions in the context of parole. An experimental design was used to explore 
the effects of monitoring frequency, feedback timing, and consequence certainty. Prior to the 
examination of relapse and recidivism outcomes, it was essential to examine the degree to which 
there was fidelity in the three conditions.  
 According to the design, it would be expected that the Experimental and Control Group I 
would have been drug tested at far higher rates than the Control Group II. Further, it would have 
been expected that the Experimental and Control Group I would be tested at the same rate. To 
determine the degree of differential testing, the frequencies of drug testing among the conditions 
were examined across six and 12 month intervals. Six months marked the end of the conditions 
and the 12 months is used to observe six month post-program experiences. Repeated measures 
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analysis of variance (ANOVA) models were used to observe differences in the proportionality or 
means amongst conditions, trends over time, and performance over time for the three 
experimental conditions. ANOVA techniques were used here and throughout the analysis given 
its robustness to violations associated with dichotomous outcomes (D’Agostino, 1971; Lunney, 
1970).    
Table 3 presents a statistical summary of the results. The Experimental and Control 
Group I were tested eight times as often as Control Group II during the first six months. 
However, the Experimental and Control Group I received less testing than called for by the 
experimental model. Both groups were actually tested less than twice per week on average (MExp 
= 1.22, SE = .03 and MCI = 1.21, SE = .05).1 Pairwise comparisons revealed no statistically 
reliable weekly testing differences between the Experimental Group and Control Group I during 
the first six months post-release. As anticipated given the six month nature of the conditions, the 
rate of testing for all groups declined over time, but declined differentially by group. The 
Experimental Group continued to be tested at a significantly higher frequency than either control 
conditions during the next sixth months.  [Insert Table 3 about here] 
 It was anticipated that the Experimental and Control Group I would be sanctioned more 
frequently than Control Group II. To determine the degree to which the Experimental Group 
received certain consequences for their actions, the percentage receiving jail time and the 
                                                          
1 The reason for the below average tests per week was that the initial protocol called for tests to be administered 7 
days a week. However, weekend staffing issues at the local jail led to tests only being administered during the 
traditional work week. The protocol was revised to 5 days a week weeks prior to the start of the program. Test per 
week data use 7 as a denominator, which lowers calculated averages.   
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average number of jail received were examined. Repeated measures ANOVA models were used 
to explore group differences. 
The experimental conditions totaled 23,557 overall jail days for positive drug tests or 
non-compliance with supervision terms across the first year of parole. Each positive test resulted 
in incarceration for members of the Experimental Group. As a result, the Experimental Group 
was most likely to have received a jail sanction. Relative to the control conditions, the 
Experimental Group was four times more likely to be jailed six months after release and 
members were twice as likely to be jailed after a year in the community (see Table 3). The 
control conditions did not receive immediate jail sanctions for positive drug tests. They were, 
however, placed in jail for non-compliance with community supervision terms. Pairwise 
comparisons indicated there were no differences between Control Group I and Control Group II 
with regard to likelihood of being placed in jail. Examination of the overall average of the 
number of jail days indicates there were no differences between groups. This average includes 
those who were and were not placed in jail. Through the use of sub-group analysis of those who 
were placed in jail, the results indicate that the Experimental Group was jailed for significantly 
shorter stays than the control conditions. At six months post-release, Control Group I and 
Control Group II were jailed for three times as many days as the Experimental Group. Control 
Group I was jailed for nearly four times as many days as the Experimental Group one year after 
release. In summary, the results show the Experimental Group was most likely to have received a 
jail sanction, while the control groups received longer stays for fewer jail placements.       
 To examine the degree of treatment referral experienced by participants, the percentage 
of participants admitted to treatment six months post-release were examined. A one-way 
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ANOVA model was used to assess group differences. The results indicate that while members of 
the Experimental and Control Group I were assessed and referred to treatment for each drug test 
positive or violation while in the program, members of Control Group I were significantly more 
likely to be admitted to and receive treatment services [F(2, 522)=4.56, p<.01]. Nearly 50% of 
Control Group I was admitted to treatment, while approximately a third of the Experimental and 
Control Group II began treatment services.   
The results confirm that varying conditions were implemented with a high degree of 
fidelity to the conditional design. Drug testing, sanction, and treatment referral portions of the 
conditions appeared to be fully implemented. Both the Experimental and Control Group I were 
more likely to be drug tested at a substantial rate while in the program. Both groups were 
assessed and/or referred to treatment for positive drug tests or violations of testing procedures, 
but this did not always result in treatment admission. Members of Control Group I were 
substantially more likely to be admitted relative to the Experimental and Control Group II.  
Relapse Outcomes 
A variety of statistical techniques were used to assess the effect of the conditions on 
relapse and recidivism outcomes. Repeated measures ANOVA models were used to determine 
the significance of differences between experimental conditions. Six and 18 month follow-up 
intervals were examined. These periods respectively represented the end of the first phase of the 
experimental conditions and the end of the study period. Survival analysis techniques were used 
to determine if there are significant differences between groups with regard to the timing of 
relapse and recidivism events. Kaplan-Meier survival estimates were produced to assess between 
group differences. Log-Rank test statistics were assessed (Cox, 1972). Where appropriate, 
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alternative test statistics were used. Wilcoxon (Breslow, 1970) and Tarone-Ware (Tarone & 
Ware, 1977) test statistics both emphasize group differences towards the beginning of the follow-
up period. Wilcoxon is regarded as being more sensitive to initial differences, while Tarone-
Ware is conservative and robust for non-constant survival curves (Tarone & Ware, 1977). 
Tables 4 and 5 present statistical analyses and effect sizes for relapse results. The 
experimental conditions submitted a total of 2,378 positive drug tests across 18 months. Pairwise 
comparisons revealed that the Experimental and Control Group I were significantly more likely 
to submit a positive test relative to Control Group II. The Experimental Group had the lowest 
rate (11%) of positive tests during the first six months. Twenty percent of the tests administered 
to Control Group I resulted in a positive test, while 24% of the tests submitted by Control Group 
II were positive. Over time, the Experimental Group maintained the lowest rate of positive drug 
tests. This ratio of testing was observed despite two trends. First, a higher proportion of 
participants in the Experimental and Control Group I tested positive at least once. Second, 
members of Experimental Group and especially Control Group I tested positive much faster than 
Control Group II. These differences were observed relatively early in to the follow-up period 
[Wilcoxon χ2(2, N = 529)=25.18, p<.001; Tarone-Ware χ2(2, N = 529)=25.84, p<.001] and can 
be attributed to the testing protocol, which required Experimental and Control Group I to test 
immediately after release, while Control Group II group was tested monthly. 
The timing to the first positive test was statistically significant and more pronounced 
between groups across the remainder of the study period. On average, Control Group I tested 
positive 14 days faster than the Experimental Group and 125 days quicker than Control Group II. 
These findings reinforce trends observed during the first six months, which suggest that drug use 
was more likely to be detected among Experimental and Control I Groups. In all, these findings 
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suggest that despite being watched more closely and receiving negative sanctions for positive 
drug tests, the Experimental Group showed substantially lower rates of drug use.2 [Insert Table 
4 and Table 5] [Insert Figure A and Figure B] 
Recidivism Outcomes 
Tables 4 and 5 also summarize information on recidivism outcomes. The Experimental 
Group was significantly less likely to have recidivated during the first six months; the time they 
were monitored most closely in the program. Four percent of the Experimental Group was re-
arrested at this time. Comparatively, 9% of Control Group II and 13% of the Control Group I had 
recidivated. The time to recidivism results at six months indicated that in addition to reduced 
likelihood, members of the Experimental Group experienced delays in timing to re-arrest. On 
average, members of the Experimental Group were re-arrested three days later than Control 
Group II and five days after Control Group II.  
The pattern of recidivism persisted across the study period as Control Group I remained 
most likely to be re-arrested. Twenty-nine percent of Control Group I recidivated, while 25% of 
Control Group II and 22% of the Experimental Group were re-arrested. Pairwise comparisons 
indicated that Control Group I was significantly more likely to have recidivated relative to the 
Experimental Group. However, the likelihood of recidivism was relatively equivalent between 
                                                          
2 As a check on the sensitivity of the results, random effect probit models were estimated. The random effect models 
allowed for individual variation in the response to the experimental conditions. There were no differences between 
the random effect and ANOVA models with regard to the experimental conditions. Identical results were obtained. 
The random effect models did caution the interpretation of the interaction effects of time for the proportion of 
participants with at least one positive and the main effects of time in the rate of positive testing. It is clear the group 
differences present at six months remain at 18 months for both indicators of relapse, which explains why the effect 
of time was not significant in the random effect models. As a result, the effect of time should be interpreted from the 
ANOVA models with this context in mind. 
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the Experimental and Control Group II at 18 months as no significant comparisons were 
observed. Across the study period, the time to re-arrest was not significant as the averages 
between groups converged.3 
DISCUSSION AND CONCLUSION 
 The purpose of this study was to explore the effectiveness of conditions designed to 
provide frequent, random drug testing with consequences for drug use to reduce levels of relapse 
and recidivism. Through the use of an experimental design, participants were randomly assigned 
to conditions that varied with regard to the frequency of drug testing, randomness of drug testing, 
consequences for drug use, and timing of consequences of drug use. The design allowed for 
determining the extent to which frequent, random tests, immediate feedback, and immediate 
sanctions were more effective than simply frequent tests or standard community supervision 
procedures. The results confirm that frequent monitoring of drug use with randomized testing 
protocols, immediate feedback, and certain consequences for drug use is effective in lowering 
rates of relapse and recidivism. 
 The Experimental Group showed substantially lower rates of relapse and recidivism as 
compared to participants in Control Group I who received frequent monitoring of drug use with 
randomized testing and delayed feedback and consequences and participants in Control Group II 
who were not tested randomly and received standard delayed feedback and consequences. These 
effects appeared during the initial six month period following release into the community when 
                                                          
3 Random effect probit models were also estimated to check the sensitivity of recidivism outcomes. Once again, 
identical results were obtained. There were no differences between the random effect and ANOVA models.  
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random testing for the Experimental and Control Group I were most active and largely persisted 
throughout the 12 month follow-up period when the intensity of the conditions lessened by 
design. While both the Experimental and Control Group I were detected for relapse much faster 
than Control Group II, the timing to re-arrest was significantly delayed for Experimental and 
Control Group I within the first six months after release. While the effect sizes for these effects 
would be categorized as small (see Table 4), they are of practical importance.  For example, for 
the proportion of positive tests outcome, the Experimental Group show approximately half the 
rate at six months and two-fifths the rate at 18 months. In terms of recidivism, similar patterns 
hold at six months. Overall, the results confirm that exposure to frequent, random testing and 
certain and swift consequences significantly lower relapse and recidivism rates during the 
process of transition into the community. 
Unfortunately, the short-term findings did not translate to long-term effects. Behavioral 
changes observed from participation in the conditions dissipated once participants were not 
subject to testing and sanction protocols. It should be of no surprise that the removal of swift and 
certain consequences would dramatically influence learned processes and allow for reversions to 
past behavior. Swiftness and certainty of sanction are critical components of deterrence theory 
(Boyum, Caulkins, & Kleiman, 2010; Durlauf & Nagin, 2011; O’Connell et al., 2011). The 
deterrent value of the experimental conditions were weakened and replaced by standard parole 
supervision where the threat of consequences was not as imminent.    
The findings of this study do lend support to the HOPE model and its generalizability to 
parolees with substance use histories. Reduced rates of positive drug testing can be achieved.  
HOPE produced larger reductions than the current study. This is largely due to the process by 
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which participants entered the experimental conditions. In HOPE, participants were referred to 
the program after a series of positive drug tests or missed tests or appointments. Participants in 
the current study paroled directly to the experimental conditions. Hence, the baseline ratio of 
positive drug testing was considerably higher for HOPE participants. Through the examination 
of the Experimental Group and Control Group II, the current study achieved a 54% reduction 
[(24-11)/24*100] in the rate of positive drug tests at six months and a 42% reduction [(26-
15/26*100] at 18 months. These findings are comparable, but slightly lower than the trends 
observed in Washington where parolees entered conditions in a similar manner (Hawkens & 
Kleiman, 2011).  
Recidivism reductions were also consistent with HOPE. In the randomized controlled 
trial of HOPE with one year follow-up, 21% of HOPE participants and 47% of the control group 
were re-arrested, which equates to a 55% reduction [(47-21)/47*100]. This is comparable to the 
rates of the of the current study, where at six months the Experimental Group was half as likely 
to be re-arrested relative to Control Group II. Within this time frame, a 56% reduction in 
recidivism was observed [(9-4/9*100]. Across 18 months, the Experimental Group recidivated at 
a lower rate than Control Group II but these differences were substantive, rather than statistically 
significant.     
A substantial number of jail days were received, with many of these days being 
accumulated by a small fraction of participants. Mean averages per participant totaled to 47 days, 
with a median value of three days. The capacity of a local jail to incur such a population is a 
critical issue. Hawken and Kleiman (2009) suggested that the benefits of the HOPE model can be 
attained without a dramatic increase in the use of jail resources. Even though HOPE and the 
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Experimental Group participants were more likely to be placed in jail as a result of testing 
violations, the number of jail days consumed by participants did not increase. The number of jail 
days consumed by the Experimental Group was a third lower than Control I and Control II 
groups. Hawken and Kleiman (2011) also observed trends that suggest considerable reductions 
in the use of jail and prison beds with parolee participants. Given the use of temporary jail 
placements for parolees and the dilemma of available bed space, the ability to decrease the use of 
jail resources is a key observation of the current study. 
A number of observations speak to the differences in study populations and the difficulty 
of managing parolees. Participants in the current study were observed to have higher rates of 
positive testing and higher proportions of participants who tested positive. Over time, the rate 
and proportions decreased for HOPE participants as testing and sanction conditions were eased. 
The opposite was observed in the current study; once conditions ended the rates and proportions 
increased. The rate of recidivism also increased with longer time in the community. These results 
are likely due to parolee status. Gill (2010) found that when probationers and parolees were 
exposed to similar intensities of supervision and surveillance, parolees were more at-risk for 
supervision term violations and recidivism than probationers. Even with this heightened risk, the 
current study did find short-term reductions in drug use and recidivism. With these benefits, it is 
assumed that resource allocation and management decision value of HOPE is likely to transfer to 
parole staff (see Hawken & Kleinman, 2009; Hawken, 2010).  
Kleiman (1988; Kleiman et al., 2003) has argued that drug testing and sanction schedules 
may be more effective than traditional substance abuse treatment services that rely upon coerced 
referral and participation. While the aim of this study was not to test Kleiman’s claim, the 
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findings do provide some insight. Namely, the observed partial eta-squared effect sizes in the 
current study were small for drug use and recidivism. Effect sizes generated from meta-analyses 
of various drug treatment interventions with offenders in prison or the community also tend to be 
small for drug use (Mitchell et al., 2012; Mitchell et al., 2007) and recidivism (Aos, Phipps, 
Barnoski, & Lieb,  2001; Chanhatasilpa et al., 2000; Mitchell et al., 2012; Mitchell et al., 2007; 
Perry et al., 2009; Prendergast, 2009).  This research suggests that the effect of both types of 
intervention may be more similar than divergent. Additional research is needed to directly test 
the value of testing and sanction schedules versus treatment.   
   A few limitations need to be addressed. First, it is the case that parole officers were 
nested within the different conditions raising the potential confound of intervention provider with 
intervention.  While this concern cannot be entirely dismissed, it can be pointed out that the 
assignment of intervention condition to office was done randomly.  This precluded the possibility 
that the “best” office was selected for the experimental condition.  Further, there were multiple 
parole agents in each office minimizing the chances that there was a “star” parole agent. Nine 
parole agents managed the Experimental Group caseload in Field Office A and 8 agents managed 
the Control Group I and II caseload in Field Office B.  Finally, there were no systematic results 
observed when results are analyzed at the level of agent.  Nevertheless, future research will have 
to sort out the impact of parole agent behavior.   
Second, low rates of admission in substance abuse treatment were observed. Substance 
abuse treatment in the community has the potential to reduce relapse and recidivism (Aos, 
Miller, & Drake, 2006; Chandler, Fletcher, & Volkow, 2009; Chanhatasilpa, MacKenzie, & 
Hickman, 2000; MacKenzie, 2006). It remains unclear if the combination of close monitoring 
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and treatment would have contributed to overall conditions effect. The sanction emphasis 
without a balance of service provision likely limited the potential promise of the conditions 
(Fletcher et al., 2009). Third and similarly, the conditions may have been enhanced if the actual 
number of random tests administered was twice per week. The average number of tests was 
slightly more than one per week.  
It is critical that future replications of the HOPE model for parolee populations consider 
two components. First, the combination of randomized drug testing and swift and certain 
sanctions is essential. Randomized testing by itself is not enough to contribute to HOPE-based 
effects. Drug test results and the subsequent sanction must be immediate. In order to replicate the 
findings of this study, results and sanctions must be swifter than the HOPE model. For the 
current trial, randomized drug tests were administered to the Experimental Group at the local 
county jail, results were instantaneous, and the jail sanction was delivered within minutes of the 
test result. As evidenced from Control Group II, the three to four day delay in randomized drug 
test results diluted the swiftness of the sanctioning process. A comparable level of delay for the 
Control Group II condition is built in to the HOPE model, where a violation hearing is held to 
deliver the sanction. Future replications with parolees that use delays by design are not likely to 
reproduce outcomes associated with HOPE. 
Second, the length of randomized drug testing protocol may need to be administered for a 
longer period of time than that which is proscribed by the HOPE model. The length of 
randomized testing in the current trial was four months longer than HOPE. Longer periods of 
randomized testing at least once a week with immediate test results and sanctions may be 
necessary for parolees to reinforce the deterrent effect. It is clear that parolee drug use behaviors 
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increased once the conditions were relaxed and returned to standard monthly testing conditions 
with delayed results and standard graduated sanctions. 
This study adds to the emerging body of evidence that strategies based upon sanction 
certainty are needed (Durlauf & Nagin, 2011; Kleiman, 2009). Additional quality evidence is 
necessary to continue to generalize and refine findings from HOPE to parolee populations. 
Particular attention must be paid to the relative swiftness of drug test results and certain 
sanctions as well as the period of exposure to randomized testing.   
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Table 1: Demographic Characteristics of Participants (n=529) 
 Experimental 
(n=281) 
Control I 
(n=136) 
Control II 
(n=112) 
Total 
(n=529) 
     
Age 34 33 33 33 
Race/Ethnicity     
    % Black 87% 93% 87% 89% 
Educational Background      
    % Less High School 55% 53% 55% 55% 
    % High School Grad 19% 21% 18% 19% 
    % More Than High    
    School 
26% 26% 26% 26% 
Marital Status     
    % Single 77% 75% 72% 76% 
    % Married 11% 15% 16% 13% 
    % Divorced 12% 9% 10% 11% 
     
Number of Charges 2 2 2 2 
Conviction Offense     
    % Drug  32% 36% 29% 32% 
    % Person  24% 20% 20% 23% 
    % Property 37% 36% 41% 38% 
    % Public Safety 6% 7% 10% 7% 
Prior Jail Time 53% 55% 55% 54% 
Prior Prison Time 53% 58% 59% 56% 
Prior Jail or Prison Time 68% 72% 76% 71% 
Risk Assessment A     
    % High 11% 12% 13% 12% 
    % Medium 32% 32% 37% 33% 
    % Low 56% 54% 49% 55% 
Risk Assessment P     
    % High 17% 18% 22% 19% 
    % Medium 46% 48% 52% 48% 
    % Low 36% 32% 25% 33% 
Alcohol Parole Condition 80% 73% 78% 78% 
     
Primary Drug of Choice     
    % Alcohol 26% 29% 28% 27% 
    % Marijuana 14% 9% 15% 13% 
    % Cocaine 16% 21% 20% 19% 
    % Heroin 14% 10% 13% 12% 
    % Missing  30% 32% 23% 29% 
Used Alcohol 88% 77% 75% 82% 
     Age Alcohol 16 17 17 17 
     Times Used Past 30 
Days 
9 8 10 9 
Used Cocaine 57% 58% 63% 58% 
     Age Cocaine 25 24 24 24 
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     Times Used Past 30 
Days 
10 9 9 9 
Used Heroin 26% 24% 29% 26% 
     Age Heroin 21 20 19 20 
     Times Used Past 30 
Days 
12 26 10 15 
Used Marijuana 69% 61% 65% 66% 
     Age Marijuana 16 16 16 16 
     Times Used Past 30 
Days 
8 8 9 8 
Used Methadone 10% 4% 8% 8% 
Used Barbiturates 4% 3% 0% 3% 
Used Hallucinogens 4% 4% 1% 3% 
Used Inhalants 1% 0% 0% 1% 
*p<.05, **p<.01, ***p<.001 
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Table 2: Drug Test and Sanction Procedures by Experimental Conditions 
Procedure Experimental Group Control I  Control II 
    
Testing Dates Required to call daily 
(Monday – Friday) 
Required to call daily 
(Monday – Friday) 
No daily calls 
    
Testing Protocol Random drug test Random drug test Routine DOC drug test 
    
Testing Outcome Instant drug test results Routine laboratory test 
results – 3 to 4 day delay 
Routine laboratory test 
results – 3 to 4 day delay 
    
Sanction for 
Positive Test 
Immediate sanctions for 
positive drug test (3 jail 
days each instance) 
Standard sanctions for 
positive drug test 
(graduated; first is 
mandatory substance 
abuse assessment, 
second is mandatory 
outpatient treatment and 
raised supervision level, 
and third is review for 
inpatient treatment or 
parole violation and 
raised supervision level). 
Standard sanctions for 
positive drug test 
(graduated; first is 
mandatory substance 
abuse assessment, 
second is mandatory 
outpatient treatment and 
raised supervision level, 
and third is review for 
inpatient treatment or 
parole violation and 
raised supervision level). 
    
Sanction for Non-
Compliance with 
Testing 
Immediate sanctions for 
failure to appear for 
testing (3 jail days each 
instance) 
Standard sanction for 
failure to appear 
(graduated; first is 
additional report to 
agent for testing, second 
is additional report to 
agent for testing plus 
referral for substance 
abuse treatment, and 
third is additional report 
to agent for testing plus 
raised supervision level 
and minimum 3 jail 
days). 
Standard sanction for 
failure to appear 
(graduated; first is 
additional report to 
agent for testing, second 
is additional report to 
agent for testing plus 
referral for substance 
abuse treatment, and 
third is additional report 
to agent for testing plus 
raised supervision level 
and minimum 3 jail 
days). 
    
Treatment 
Assessment Process 
Required treatment 
assessment in jail 
Standard referral process 
at agent discretion 
Standard referral process 
at agent discretion 
    
Treatment Referral 
Process 
Offered drug treatment 
following assessment 
Standard referral process 
may result in treatment 
intake at provider 
discretion 
Standard referral process 
may result in treatment 
intake at provider 
discretion 
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Table 3: Implementation Check of Differential Testing and Sanction (n=529) 
 At 6 Months At 12 Months    
 M SE M SE F df ηp2 
        
        
Frequency of Tests        
Time  22.39 .70 4.24 .27 664.98*** 1, 526 .56 
Group      131.17*** 2, 526 .33 
Time x Group     125.23*** 2, 526 .32 
    Experimental 31.56 .89 6.45 .34    
    Control I  31.23 1.29 2.98 .49    
    Control II 4.39 1.42 3.30 .54    
        
Frequency of Tests by Week        
Time  .87 .03 .31 .01 707.92*** 1, 526 .57 
Group      140.56*** 2, 526 .35 
Time x Group     114.73*** 2, 526 .30 
    Experimental 1.22 .03 .44 .01    
    Control I 1.21 .05 .39 .02    
    Control II .17 .05 .09 .02    
        
Jail Percent Received        
Time  .40 .02 .45 .02 71.73*** 1, 526 .12 
Group      90.43*** 2, 526 .26 
Time x Group     11.46*  2, 526 .04 
    Experimental .70 .02 .74 .03    
    Control I .17 .04 .35 .04    
    Control II  .15 .04 .27 .04    
        
Overall Jail Days        
Time  13.77 1.50 46.92 3.84 140.09*** 1, 526 .21 
Group      .34 2, 526 .001 
Time x Group     2.01 2, 526 .01 
    Experimental 17.20 1.91 46.34 4.88    
    Control I 11.62 2.75 52.68 7.02    
    Control II  12.50 3.03 41.73 7.73    
        
Jail Days, If Jaileda        
Time  58.58 4.02 160.80 9.22 225.71*** 1, 233 .49 
Group      51.83*** 2, 233 .31 
Time x Group     47.21*** 2, 233 .04 
    Experimental 24.65 2.63 60.96 6.03    
    Control I 68.74 7.68 226.13 17.61    
    Control II  82.35 8.93 195.29 20.48    
*p<.05, **p<.01, ***p<.001 
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a. Analysis and reported statistic for sub-group of conditions who received jail sanction 
associated with the conditions or jail sanction for behavior extraneous to the program. This 
translates to 70% of the Experimental Group, 17% of Control I, and 15% of Control II. 
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Table 4: Repeated Measures ANOVA Relapse and Recidivism Outcomes (n=529)  
 At 6 Months At 18 Months    
 M SE M SE F df ηp2 
        
At Least One Positive        
Time  .53 .02 .65 .02 59.45*** 1, 526 .10 
Group      11.54*** 2, 526 .04 
Time x Group     5.84** 2, 526 .02 
    Experimental .61 .03 .72 .03    
    Control I .65 .04 .69 .04    
    Control II  .35 .05 .53 .04    
        
Proportion Positive        
Time  .19 .01 .21 .01 6.79** 1, 526 .01 
Group      10.75*** 2, 526 .04 
Time x Group     2.14 2, 526 .01 
    Experimental .11 .02 .15 .01    
    Control I .20 .02 .21 .02    
    Control II  .24 .02 .26 .02    
        
Re-arrest        
Time  .09 .01 .25 .02 88.93*** 1, 526 .15 
Group      2.88** 2, 526 .01 
Time x Group     .13 2, 526 .001 
    Experimental .04 .01 .22 .03    
    Control I .13 .02 .29 .04    
    Control II  .09 .02 .25 .04    
*p<.05, **p<.01, ***p<.001 
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Table 5: Timing (in Days) to Relapse and Recidivism Outcomes (n=529) 
 Experimental 
(n=281) 
Control I  
(n=136) 
Control II 
 (n=112) 
 
 M SE M SE M SE Log-Rank 
statistic 
        
First 6 Months        
First positive   114 4.07 100 5.92 143 5.62 25.76*** 
First re-arrest 178 1.27 175 2.14 173 3.07 9.27** 
        
Total Study Period        
First positive   234 12.98 220 19.46 345 20.35 17.74*** 
First re-arrest  484 7.38 453 12.91 470 13.75 2.69 
*p<.05, **p<.01, ***p<.001 
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Figure A: Relapse Failure Curves by Experimental Condition (n=529) 
 
 
Note: Log-Rank χ2(2, N = 529)=17.74, p<.001; Wilcoxon χ2(2, N = 529)=21.32, p<.001; Tarone-
Ware χ2(2, N = 529)=20.09, p<.001. 
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Figure B: Recidivism Failure Curves by Experimental Condition (n=529) 
 
 
Note: Log-Rank χ2(2, N = 529)=2.69, p=.26; Wilcoxon χ2(2, N = 529)=3.10, p=.21; Tarone-Ware 
χ2(2, N = 529)=2.90, p=.24. 
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